Investigating how to improve corneal cross-linking treatments for keratoconus
Determining the Efficacy of Corneal Cross-Linking Protocols using Brillouin Microscopy
This study is looking at how to make treatments for keratoconus better by using a special imaging technique to create 3D maps of the cornea, which will help doctors understand how different treatments work and improve care for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cleveland Clinic Lerner Com-Cwru NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10875496 on NIH RePORTER |
What this research studies
This research focuses on improving the treatment of keratoconus, a condition that weakens the cornea and can lead to vision loss. The team will use a cutting-edge technique called Brillouin microscopy to create detailed 3D maps of the cornea, allowing them to assess how effective different corneal cross-linking protocols are. By understanding the mechanical properties of the cornea before and after treatment, the researchers aim to predict the long-term outcomes of these procedures more accurately. This approach could lead to better treatment plans tailored to individual patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with keratoconus or related corneal ectatic diseases.
Not a fit: Patients with stable corneas or those who do not have keratoconus may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for keratoconus, improving vision and quality of life for patients.
How similar studies have performed: Previous research using Brillouin microscopy has shown promising results in assessing corneal mechanics, indicating that this approach could be effective.
Where this research is happening
Cleveland, United States
- Cleveland Clinic Lerner Com-Cwru — Cleveland, United States (Active)
Researchers
- Principal investigator: Randleman, James Bradley — Cleveland Clinic Lerner Com-Cwru
- Study coordinator: Randleman, James Bradley
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.